Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.
Greenfield
J R
JR
Department of Endocrinology, St Vincent's Hospital, Sydney, NSW.
Chisholm
D J
DJ
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D017035:Pravastatin / Q000627:therapeutic use; D012307:Risk Factors
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D001262:Atenolol; D008687:Metformin; D017035:Pravastatin